Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Grand Canyon Education
LOPE
$3.79B
| $8.24M | ﹤0.01% |
49,559
+13,473
| +37% | +$2.44M |
|
1827
Applied Optoelectronics
AAOI
$11B
| $8.22M | ﹤0.01% |
235,704
+9,930
| +4% | +$296K |
|
1828
AST SpaceMobile
ASTS
$21.4B
| $8.21M | ﹤0.01% |
113,076
-18,407
| -14% | -$1.31M |
|
1829
CALL
MGM Resorts International
MGM
$11.1B
| $8.21M | ﹤0.01% |
225,000
+125,000
| +125% | +$4.24M |
|
|
DOCU
1830
PUT
DocuSign
DOCU
$12.2B
| $8.21M | ﹤0.01% |
120,000
-53,200
| -31% | -$3.68M |
|
1831
NIO
NIO
$11.3B
| $8.21M | ﹤0.01% |
1,609,237
+765,917
| +91% | +$4.73M |
|
1832
CALL
TeraWulf
WULF
$8.14B
| $8.2M | ﹤0.01% |
713,800
+509,800
| +250% | +$6.83M |
|
1833
Armstrong World Industries
AWI
$7.68B
| $8.18M | ﹤0.01% |
42,803
+1,766
| +4% | +$337K |
|
|
PRMB
1834
CALL
Primo Brands
PRMB
$8.97B
| $8.18M | ﹤0.01% |
500,000
| – | – |
|
|
PRMB
1835
PUT
Primo Brands
PRMB
$8.97B
| $8.18M | ﹤0.01% |
500,000
| – | – |
|
|
EXE
1836
PUT
Expand Energy Corp
EXE
$21.9B
| $8.17M | ﹤0.01% |
74,000
-1,099,500
| -94% | -$122M |
|
1837
IDEAYA Biosciences
IDYA
$3.53B
| $8.15M | ﹤0.01% |
235,872
-14,509
| -6% | -$463K |
|
1838
PUT
Liquidia Corp
LQDA
$6.45B
| $8.15M | ﹤0.01% |
236,300
-125,000
| -35% | -$3.56M |
|
1839
VF Corp
VFC
$5.79B
| $8.15M | ﹤0.01% |
450,513
-451,790
| -50% | -$7.32M |
|
1840
Arrow Electronics
ARW
$10.6B
| $8.14M | ﹤0.01% |
73,915
-21,774
| -23% | -$2.47M |
|
1841
Onto Innovation
ONTO
$20.6B
| $8.14M | ﹤0.01% |
51,548
-41,574
| -45% | -$5.9M |
|
1842
Goodyear
GT
$1.78B
| $8.13M | ﹤0.01% |
928,093
+6,329
| +0.7% | +$49.9K |
|
1843
Sportradar
SRAD
$4.02B
| $8.12M | ﹤0.01% |
341,700
+260,137
| +319% | +$6.26M |
|
1844
Service Corp International
SCI
$11.3B
| $8.12M | ﹤0.01% |
104,096
-80,493
| -44% | -$6.44M |
|
1845
Archer Aviation
ACHR
$5.37B
| $8.11M | ﹤0.01% |
1,078,494
+145,081
| +16% | +$1.37M |
|
1846
Mineralys Therapeutics
MLYS
$2.31B
| $8.1M | ﹤0.01% |
223,283
-430,547
| -66% | -$17.3M |
|
|
NBIS
1847
CALL
Nebius Group N.V.
NBIS
$69.3B
| $8.1M | ﹤0.01% |
96,800
-229,000
| -70% | -$23.7M |
|
1848
PUT
Travere Therapeutics
TVTX
$5.79B
| $8.1M | ﹤0.01% |
+212,000
| New | +$6.89M |
|
1849
PUT
Hims & Hers Health
HIMS
$6.71B
| $8.09M | ﹤0.01% |
+249,000
| New | +$10.7M |
|
1850
CALL
Cinemark Holdings
CNK
$4.37B
| $8.08M | ﹤0.01% |
+347,800
| New | +$9.14M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.